PAK4 and glioblastoma: Additionally, we applied the pharmacological PAK4 inhibitor PF-3758309 (PAK4i) [45] to LN229 and U343MG cells to confirm the link between PAK4 and glioblastoma cell radiosensitivity (Figure 3D,E).